Immune cell interactions in tuberculosis
JAL Flynn, J Chan - Cell, 2022 - cell.com
Despite having been identified as the organism that causes tuberculosis in 1882,
Mycobacterium tuberculosis has managed to still evade our understanding of the protective …
Mycobacterium tuberculosis has managed to still evade our understanding of the protective …
[HTML][HTML] Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Tuberculosis is the leading infectious disease killer globally due to a single pathogen.
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …
[HTML][HTML] Prevention of tuberculosis in macaques after intravenous BCG immunization
Mycobacterium tuberculosis (Mtb) is the leading cause of death from infection worldwide.
The only available vaccine, BCG (Bacillus Calmette–Guérin), is given intradermally and has …
The only available vaccine, BCG (Bacillus Calmette–Guérin), is given intradermally and has …
Intravenous Bacille Calmette–Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis
EC Larson, AL Ellis-Connell, MA Rodgers… - Nature …, 2023 - nature.com
Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is the most common cause of
death in people living with human immunodeficiency virus (HIV). Intra-dermal Bacille …
death in people living with human immunodeficiency virus (HIV). Intra-dermal Bacille …
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB. 1.16 infection in nonhuman primates
M Gagne, BJ Flynn, SF Andrew, J Marquez… - Nature …, 2024 - nature.com
A mucosal route of vaccination could prevent severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) replication at the site of infection and limit transmission. We …
coronavirus 2 (SARS-CoV-2) replication at the site of infection and limit transmission. We …
Vaccination against tuberculosis: revam** BCG by molecular genetics guided by immunology
SHE Kaufmann - Frontiers in immunology, 2020 - frontiersin.org
Tuberculosis (TB) remains a major health threat. Although a vaccine has been available for
almost 100 years termed Bacille Calmette-Guérin (BCG), it is insufficient and better vaccines …
almost 100 years termed Bacille Calmette-Guérin (BCG), it is insufficient and better vaccines …
MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates
JS Woodworth, V Contreras, D Christensen… - Nature …, 2024 - nature.com
Abstract Development of new vaccines tailored for difficult-to-target diseases is hampered by
a lack of diverse adjuvants for human use, and none of the currently available adjuvants …
a lack of diverse adjuvants for human use, and none of the currently available adjuvants …
Update on TB vaccine pipeline
C Martin, N Aguilo, D Marinova, J Gonzalo-Asensio - Applied Sciences, 2020 - mdpi.com
In addition to antibiotics, vaccination is considered among the most efficacious methods in
the control and the potential eradication of infectious diseases. New safe and effective …
the control and the potential eradication of infectious diseases. New safe and effective …
[HTML][HTML] Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques
Analysis of multi-modal datasets can identify multi-scale interactions underlying biological
systems but can be beset by spurious connections due to indirect impacts propagating …
systems but can be beset by spurious connections due to indirect impacts propagating …
Targeting immunometabolism in host defence against Mycobacterium tuberculosis
In the face of ineffective vaccines, increasing antibiotic resistance and the decline in new
antibacterial drugs in the pipeline, tuberculosis (TB) still remains pandemic. Exposure to …
antibacterial drugs in the pipeline, tuberculosis (TB) still remains pandemic. Exposure to …